Kawashima_2022_BMC.Neurol_22_175

Reference

Title : Memantine for the patients with mild cognitive impairment in Parkinson's disease: a pharmacological fMRI study - Kawashima_2022_BMC.Neurol_22_175
Author(s) : Kawashima S , Matsukawa N
Ref : BMC Neurol , 22 :175 , 2022
Abstract : Kawashima_2022_BMC.Neurol_22_175
ESTHER : Kawashima_2022_BMC.Neurol_22_175
PubMedSearch : Kawashima_2022_BMC.Neurol_22_175
PubMedID: 35562711

Related information

Citations formats

Kawashima S, Matsukawa N (2022)
Memantine for the patients with mild cognitive impairment in Parkinson's disease: a pharmacological fMRI study
BMC Neurol 22 :175

Kawashima S, Matsukawa N (2022)
BMC Neurol 22 :175